Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective
May 2017
You'll see fewer payers requiring a trial of immediate-release oxybutynin for overactive bladder before approving an alternative.
Oxybutynin IR has been the least expensive...but the cost of some of the other antimuscarinics are coming down as more of them go generic.
For mild symptoms of overactive bladder, stick with nondrug measures first...limiting caffeine, bladder training, etc. Explain these strategies can work as well as meds...if patients are diligent.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote